Literature DB >> 12585792

Thymoma: a review of the clinical and pathological findings in 65 cases.

Brita Sperling1, Jeff Marschall, Renee Kennedy, Punam Pahwa, Rajnl Chibbar.   

Abstract

INTRODUCTION: Although rare, thymoma is the most common tumour of the anterior mediastinum. In an effort to assess the clinical and pathologic characteristics of this tumour and to determine whether clinicopathologic stage or histopathologic classification correlates with clinical outcome, in the Department of Pathology and the Department of Surgery at the University of Saskatchewan we reviewed all cases of thymoma registered in the province of Saskatchewan using the database of the Saskatchewan Cancer Centre.
METHODS: In 65 patients with a diagnosis of thymoma or thymic carcinoma identified from the Saskatchewan Cancer Centre database between Jan. 1, 1960, and Dec. 31, 2000, we studied the presentation, diagnostic investigations, therapeutic interventions, tumour size, postoperative course, clinical stage, histopathologic classification, disease recurrence and mortality.
RESULTS: Of the 65 patients, 17 (26%) were asymptomatic and 11 (17%) had symptoms consistent with myasthenia gravis. Surgical resection is most commonly performed through a median sternotomy and frequently requires en bloc resection of one or more adjacent structures. The overall survival of patients with thymomawas found to correlate with the clinical stage as described by Masaoka and colleagues and with complete tumour resection. A trend to clinicopathologic correlation was observed when applying the histologic classification systems of Suster and Moran and the World Health Organisation, but this trend was not statistically significant.
CONCLUSIONS: Thymoma is a rare tumour with a variable clinical presentation. Clinical outcome correlates with clinical stage and the ability to achieve complete tumour resection.

Entities:  

Mesh:

Year:  2003        PMID: 12585792      PMCID: PMC3211673     

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  22 in total

1.  Invasive and noninvasive thymoma: distinctive CT features.

Authors:  N Tomiyama; N L Müller; S J Ellis; J R Cleverley; M Okumura; S Miyoshi; M Kusumoto; T Johkoh; S Yoshida; N Mihara; O Honda; T Kozuka; S Hamada; H Nakamura
Journal:  J Comput Assist Tomogr       Date:  2001 May-Jun       Impact factor: 1.826

2.  PATHOLOGY AND CLINICAL BEHAVIOR OF THYMOMAS. A SURVEY OF 51 CASES.

Authors:  M A LEGG; W J BRADY
Journal:  Cancer       Date:  1965-09       Impact factor: 6.860

Review 3.  Current status of the diagnosis and treatment of thymoma.

Authors:  G M Graeber; W Tamim
Journal:  Semin Thorac Cardiovasc Surg       Date:  2000-10

4.  Thymoma: trends over time.

Authors:  K H Moore; P R McKenzie; C W Kennedy; B C McCaughan
Journal:  Ann Thorac Surg       Date:  2001-07       Impact factor: 4.330

5.  Prognostic relevance of Masaoka and Müller-Hermelink classification in patients with thymic tumors.

Authors:  D Lardinois; R Rechsteiner; R H Läng; M Gugger; D Betticher; C von Briel; T Krueger; H B Ris
Journal:  Ann Thorac Surg       Date:  2000-05       Impact factor: 4.330

6.  Thymoma--the usefulness of some prognostic factors for diagnosis and surgical treatment.

Authors:  J Gawrychowski; M Rokicki; A Gabriel; B Lackowska; D Czyzewski
Journal:  Eur J Surg Oncol       Date:  2000-04       Impact factor: 4.424

7.  Primary thymic carcinomas.

Authors:  M R Wick; B W Scheithauer; L H Weiland; P E Bernatz
Journal:  Am J Surg Pathol       Date:  1982-10       Impact factor: 6.394

8.  Thymoma. A clinicopathologic review.

Authors:  J E Lewis; M R Wick; B W Scheithauer; P E Bernatz; W F Taylor
Journal:  Cancer       Date:  1987-12-01       Impact factor: 6.860

9.  Follow-up study of thymomas with special reference to their clinical stages.

Authors:  A Masaoka; Y Monden; K Nakahara; T Tanioka
Journal:  Cancer       Date:  1981-12-01       Impact factor: 6.860

10.  Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus.

Authors:  M Marino; H K Müller-Hermelink
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985
View more
  7 in total

1.  Nonmalignant pericardial effusion associated with thymic cancer.

Authors:  Tatsuya Nishi; Shinzo Takamori; Fumihiko Muta; Koichi Yoshiyama; Yasunori Iwasaki; Kazuo Shirouzu
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-05-07

Review 2.  Thymic neoplasms: a clinical update.

Authors:  Mark Mikhail; Yasmin Mekhail; Tarek Mekhail
Journal:  Curr Oncol Rep       Date:  2012-08       Impact factor: 5.075

3.  Arg and DAP3 expression was correlated with human thymoma stage.

Authors:  Hidefumi Sasaki; Nobuyuki Ide; Haruhiro Yukiue; Yoshihiro Kobayashi; Ichiro Fukai; Yosuke Yamakawa; Yoshitaka Fujii
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

4.  En bloc extended total thymectomy and extrapleural pneumonectomy in Masaoka stage IVA thymomas.

Authors:  Hee Chul Yang; Yoo Sang Yoon; Hong Kwan Kim; Yong Soo Choi; Kwhanmien Kim; Young Mog Shim; Jungho Han; Jhingook Kim
Journal:  J Cardiothorac Surg       Date:  2011-03-12       Impact factor: 1.637

5.  A single institutional experience of thymic epithelial tumours over 11 years: clinical features and outcome and implications for future management.

Authors:  H-S Lee; S T Kim; J Lee; Y S Choi; J-H Han; Y-C Ahn; K-S Lee; J S Ahn; M J Ahn; K Kim; Y M Shim; J Kim; K Park
Journal:  Br J Cancer       Date:  2007-06-26       Impact factor: 7.640

6.  Pure White Cell Aplasia and Immune Thrombocytopenia after Thymoma Resection: A Case Report and Review of the Literature.

Authors:  Michael Youssef; Tyler W Stratton; Reid C Gallant; Christine Young; Daniel Y Li; Siavash Piran
Journal:  Case Rep Hematol       Date:  2022-03-22

7.  Superior vena cava syndrome from an invasive thymoma with transcaval invasion to the right atrium.

Authors:  Ashwad Afzal; Ivan Wong; Aleksandr Korniyenko; Alex Ivanov; Berhane Worku; Iosif Gulkarov
Journal:  J Surg Case Rep       Date:  2016-04-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.